MGIC Investment Corp (MTG) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.99%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.99% | Share-based compensation / revenue. Period ending 2026-06-30. $23.82M ÷ $1.20B × 100 ≈ 1.99% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.20B USD | |
| Stock-based compensation | 23.82M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.20B | $23.82M | (m) | (m) | (m) | 1.99% | (m) | (m) |
| 2026-03-31 | (m) | $1.20B | $22.78M | (m) | (m) | (m) | 1.89% | (m) | (m) |
| 2025-12-31 | (m) | $1.21B | $24.43M | (m) | (m) | (m) | 2.01% | (m) | (m) |
| 2025-09-30 | (m) | $1.22B | $25.26M | (m) | (m) | (m) | 2.08% | (m) | (m) |
| 2025-06-30 | (m) | $1.22B | $25.91M | (m) | (m) | (m) | 2.13% | (m) | (m) |
| 2025-03-31 | (m) | $1.22B | $28.31M | (m) | (m) | (m) | 2.32% | (m) | (m) |
| 2024-12-31 | (m) | $1.21B | $31.32M | (m) | (m) | (m) | 2.59% | (m) | (m) |
| 2024-09-30 | (m) | $1.19B | $33.36M | (m) | (m) | (m) | 2.80% | (m) | (m) |
| 2024-06-30 | (m) | $1.18B | $32.38M | (m) | (m) | (m) | 2.74% | (m) | (m) |
| 2024-03-31 | (m) | $1.17B | $33.03M | (m) | (m) | (m) | 2.83% | (m) | (m) |
| 2023-12-31 | (m) | $1.16B | $31.61M | (m) | (m) | (m) | 2.74% | (m) | (m) |
| 2023-09-30 | (m) | $1.16B | $30.19M | (m) | (m) | (m) | 2.59% | (m) | (m) |
| 2023-06-30 | (m) | $1.16B | $27.94M | (m) | (m) | (m) | 2.41% | (m) | (m) |
| 2023-03-31 | (m) | $1.16B | $27.88M | (m) | (m) | (m) | 2.40% | (m) | (m) |
| 2022-12-31 | (m) | $1.17B | $24.77M | (m) | (m) | (m) | 2.11% | (m) | (m) |
| 2022-09-30 | (m) | $1.17B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $1.18B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $1.18B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.19B | $17.11M | (m) | (m) | (m) | 1.44% | (m) | (m) |
| 2021-09-30 | (m) | $1.19B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.20B | $13.80M | (m) | (m) | (m) | 1.15% | (m) | (m) |
| 2011-03-31 | (m) | $1.50B | (m) | (m) | $103.61M | (m) | (m) | (m) | Reported |
| 2010-12-31 | (m) | $1.52B | (m) | (m) | $98.59M | (m) | (m) | (m) | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $1.71B | (m) | (m) | $89.27M | (m) | (m) | (m) | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $1.72B | (m) | (m) | $81.07M | (m) | (m) | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Essent Group Ltd. (ESNT) | $5.775B | 8.49 | |
| RADIAN GROUP INC (RDN) | United States | $4.438B | 9.38 |
| NMI Holdings, Inc. (NMIH) | United States | $3.127B | |
| ASSURED GUARANTY LTD (AGO) | $3.007B | 9.37 | |
| OLD REPUBLIC INTERNATIONAL CORP (ORI) | United States | $9.155B | 8.68 |
| MBIA INC (MBI) | United States | $0.226B | -1.93 |
| OCTAVE SPECIALTY GROUP INC (OSG) | United States | $0.187B | -1.76 |